Loading...
The Beauty Health Company
SKIN•NASDAQ
Consumer Defensive
Household & Personal Products
$1.79
$-0.04(-2.19%)
The Beauty Health Company (SKIN) Financial Performance & Income Statement Overview
Review The Beauty Health Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-16.00%
↓ 16.005%
Operating Income Growth
48.23%
↑ 48.23%
Net Income Growth
70.94%
↑ 70.94%
Operating Cash Flow Growth
-25.82%
↓ 25.82%
Operating Margin
-19.48%
↓ 19.48%
Gross Margin
56.60%
↑ 56.60%
Net Profit Margin
-11.94%
↓ 11.94%
ROE
-67.93%
↓ 67.93%
ROIC
-10.28%
↓ 10.28%
The Beauty Health Company (SKIN) Income Statement & Financial Overview
Review The Beauty Health Company's (SKIN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $83.50M | $78.80M | $90.59M | $81.40M |
| Cost of Revenue | $31.15M | $38.15M | $49.65M | $33.04M |
| Gross Profit | $52.35M | $40.65M | $40.94M | $48.36M |
| Gross Profit Ratio | $0.63 | $0.52 | $0.45 | $0.59 |
| R&D Expenses | $1.22M | $1.11M | $1.16M | $2.81M |
| SG&A Expenses | $58.28M | $61.06M | $61.89M | $62.55M |
| Operating Expenses | $59.50M | $62.16M | $63.05M | $65.35M |
| Total Costs & Expenses | $90.65M | $100.32M | $112.70M | $98.39M |
| Interest Income | $2.22M | $4.88M | $4.19M | $5.36M |
| Interest Expense | $2.46M | $2.47M | $2.45M | $3.03M |
| Depreciation & Amortization | $2.00M | $9.56M | $8.92M | $8.65M |
| EBITDA | -$2.70M | -$4.32M | $11.22M | $10.34M |
| EBITDA Ratio | -$0.03 | -$0.05 | $0.12 | $0.13 |
| Operating Income | -$7.16M | -$21.52M | -$22.11M | -$16.99M |
| Operating Income Ratio | -$0.09 | -$0.27 | -$0.24 | -$0.21 |
| Other Income/Expenses (Net) | -$4.56M | $5.17M | $21.96M | $15.65M |
| Income Before Tax | -$11.72M | -$16.34M | -$151000.00 | -$1.34M |
| Income Before Tax Ratio | -$0.14 | -$0.21 | -$0.002 | -$0.02 |
| Income Tax Expense | -$1.39M | $1.95M | -$353000.00 | -$659000.00 |
| Net Income | -$10.33M | -$18.29M | $202000.00 | -$679000.00 |
| Net Income Ratio | -$0.12 | -$0.23 | $0.002 | -$0.008 |
| EPS | -$0.08 | -$0.15 | -$0.12 | -$0.005 |
| Diluted EPS | -$0.08 | -$0.15 | -$0.10 | -$0.005 |
| Weighted Avg Shares Outstanding | $124.40M | $124.06M | $123.72M | $123.12M |
| Weighted Avg Shares Outstanding (Diluted) | $124.40M | $124.06M | $141.93M | $144.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan